Literature DB >> 16091255

HIV antiretroviral therapy in resource-limited settings: experiences from Haiti.

Alysa Krain1, Daniel W Fitzgerald.   

Abstract

An unprecedented international effort to expand high activity antiretroviral therapy (HAART) to resource-poor nations has been launched. The World Health Organization (WHO) has created antiretroviral (ARV) treatment guidelines adapted to resource-poor settings. The first-line regimen is two nucleoside reverse transcriptase inhibitors (NsRTIs) and one nonnucleoside reverse transcriptase inhibitor (NNRTI). Therapy is initiated by clinical staging and CD4 T-cell counts when available. Adherence is the responsibility of health care workers. The use of ARV therapy in resource-poor settings faces several challenges, including the poverty of patients, political and social upheavals and violence, social stigma associated with HIV/AIDS, unreliable pharmacy systems, tuberculosis, and lack of trained health care workers. Using our experience in Haiti, we describe how we have addressed these challenges with the goal of increasing access to care for the poor with HIV/AIDS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091255     DOI: 10.1007/s11904-005-0025-3

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  32 in total

1.  Mbeki appoints team to look at cause of AIDS.

Authors:  P Sidley
Journal:  BMJ       Date:  2000-05-13

2.  High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire.

Authors:  C Adjé; R Cheingsong; T H Roels; C Maurice; G Djomand; W Verbiest; K Hertogs; B Larder; B Monga; M Peeters; S Eholie; E Bissagene; M Coulibaly; R Respess; S Z Wiktor; T Chorba; J N Nkengasong
Journal:  J Acquir Immune Defic Syndr       Date:  2001-04-15       Impact factor: 3.731

Review 3.  Fighting against AIDS: the Brazilian experience.

Authors:  Guido Carlos Levi; Marco Antonio A Vitória
Journal:  AIDS       Date:  2002-12-06       Impact factor: 4.177

4.  Adherence to HAART and its principal determinants in a cohort of Senegalese adults.

Authors:  Isabelle Lanièce; Mounirou Ciss; Alice Desclaux; Karim Diop; Fatou Mbodj; Barra Ndiaye; Omar Sylla; Eric Delaporte; Ibrahima Ndoye
Journal:  AIDS       Date:  2003-07       Impact factor: 4.177

Review 5.  What policymakers should know about drug resistance and adherence in the context of scaling-up treatment of HIV infection.

Authors:  Joep M A Lange; Jos Perriens; Dan Kuritzkes; Debrework Zewdie
Journal:  AIDS       Date:  2004-06       Impact factor: 4.177

6.  Antiretroviral treatment in resource-poor settings: what can we learn from the existing programmes in Thailand?

Authors:  Praphan Phanuphak
Journal:  AIDS       Date:  2004-06       Impact factor: 4.177

Review 7.  Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in Haiti.

Authors:  Arachu Castro; Paul Farmer
Journal:  Am J Public Health       Date:  2005-01       Impact factor: 9.308

8.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

Review 9.  Tuberculosis and HIV in the Caribbean: approaches to diagnosis, treatment, and prophylaxis.

Authors:  Jean William Pape
Journal:  Top HIV Med       Date:  2004 Dec-2005 Jan

10.  Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti.

Authors:  J W Pape; B Liautaud; F Thomas; J R Mathurin; M M St Amand; M Boncy; V Pean; M Pamphile; A C Laroche; W D Johnson
Journal:  N Engl J Med       Date:  1983-10-20       Impact factor: 91.245

View more
  2 in total

Review 1.  Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.

Authors:  Jessica E Hart; Christie Y Jeon; Louise C Ivers; Heidi L Behforouz; Adolfo Caldas; Peter C Drobac; Sonya S Shin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

2.  Soluble urokinase plasminogen activator receptor (suPAR) is associated with metabolic changes in HIV-1-infected Africans: a prospective study.

Authors:  Carla M T Fourie; Johannes M Van Rooyen; Annamarie Kruger; Michael H Olsen; Jesper Eugen-Olsen; Rudolph Schutte; Aletta E Schutte
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.